<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The serum concentrations of the complement inactivators C1INH, C3bINA and beta 1H have been determined in patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and their correlation with C3 and properdin factor B examined </plain></SENT>
<SENT sid="1" pm="."><plain>The incidence of immunoconglutinins (1K) in these patients was investigated </plain></SENT>
<SENT sid="2" pm="."><plain>Raised serum concentrations of C1INH and C3bINA have been found in patients with active disease, but no significant alteration was found in serum concentration of beta 1H </plain></SENT>
<SENT sid="3" pm="."><plain>An increasing incidence of positive 1K titres was found with <z:mp ids='MP_0001257'>increased length</z:mp> of disease history </plain></SENT>
<SENT sid="4" pm="."><plain>These results suggest continuing complement activation in these diseases </plain></SENT>
</text></document>